Genetic Technologies Limited (GENE)
NASDAQ: GENE · IEX Real-Time Price · USD
1.370
-0.040 (-2.84%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Genetic Technologies Revenue
Genetic Technologies had revenue of $5.78M in the twelve months ending December 31, 2023. In the fiscal year ending June 30, 2023, Genetic Technologies had annual revenue of $5.99M with 26.95% growth.
Revenue (ttm)
$5.78M
Revenue Growth
+26.95%
P/S Ratio
1.05
Revenue / Employee
$96,268
Employees
60
Market Cap
6.04M USD
Revenue Chart
* The company reports in AUD currency but revenue data is shown in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2023 | 5.99M | 1.27M | 26.95% |
Jun 30, 2022 | 4.72M | 4.63M | 5,105.78% |
Jun 30, 2021 | 90.64K | 83.84K | 1,232.38% |
Jun 30, 2020 | 6.80K | -11.12K | -62.03% |
Jun 30, 2019 | 17.92K | -122.27K | -87.22% |
Jun 30, 2018 | 140.19K | -258.57K | -64.84% |
Jun 30, 2017 | 398.76K | -438.96K | -52.40% |
Jun 30, 2016 | 837.71K | -1.50M | -64.23% |
Jun 30, 2015 | 2.34M | -2.77M | -54.20% |
Jun 30, 2014 | 5.11M | -2.35M | -31.49% |
Jun 30, 2013 | 7.46M | 485.83K | 6.96% |
Jun 30, 2012 | 6.98M | -12.83M | -64.78% |
Jun 30, 2011 | 19.81M | 12.48M | 170.26% |
Jun 30, 2010 | 7.33M | -753.79K | -9.32% |
Jun 30, 2009 | 8.08M | -6.89M | -46.01% |
Jun 30, 2008 | 14.97M | 2.48M | 19.83% |
Jun 30, 2007 | 12.49M | 5.03M | 67.42% |
Jun 30, 2006 | 7.46M | 1.97M | 35.86% |
Jun 30, 2005 | 5.49M | 3.66M | 199.03% |
Jun 30, 2004 | 1.84M | -1.12M | -37.80% |
Jun 30, 2003 | 2.95M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionGENE News
- 7 days ago - GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease - GlobeNewsWire
- 11 days ago - Join Genetic Technologies' Exclusive Live Investor Webinar and Q&A Session on June 27 - GlobeNewsWire
- 2 months ago - Appendix 4C & Quarterly Business Update – March 2024 - GlobeNewsWire
- 2 months ago - Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering - GlobeNewsWire
- 2 months ago - Genetic Technologies Announces $2 Million Registered Direct Offering - GlobeNewsWire
- 2 months ago - Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire
- 3 months ago - Genetic Technologies' Digital Strategy Ignites Significant Traction in US Market - GlobeNewsWire
- 4 months ago - GTG to launch U.S. Customer Digital Media Sales Campaign - GlobeNewsWire